Immunitybio Inc (NASDAQ:IBRX)

3.68
Delayed Data
As of Dec 05
 -0.04 / -1.08%
Today’s Change
1.21
Today|||52-Week Range
7.10
-27.42%
Year-to-Date

Today’s Trading

Previous close3.72
Today’s open3.71
Day’s range3.61 - 3.79
Volume73,825
Average volume (3 months)4,595,840
Market cap$2.5B
Data as of 3:59pm ET, 12/05/2023

Growth & Valuation

Earnings growth (last year)-16.91%
Earnings growth (this year)--
Earnings growth (next 5 years)-47.93%
Revenue growth (last year)-74.30%
P/E ratioNM
Price/Sales8,447.90
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ARWRArrowhead Pharmaceut...-1.51-6.06%
AXSMAxsome Therapeutics ...+1.19+1.76%
----
DNLIDenali Therapeutics ...-0.23-1.23%
Data as of 3:59pm ET, 12/05/2023

Financials

Next reporting dateFebruary 27, 2024
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$240.0K
Annual profit (last year)-$416.6M
Net profit margin-173,569.58%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
San Diego, California

Forecasts